Cescon, Barrieu, Flesch & Barreto and Demarest advised on the deal Bionovis executed the acquisition ot the technology to produce Trastuzumab from Samsung Bioepis. Trastuzumab, sold…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
